ALSIP, IL / ACCESSWIRE / December 29, 2023 / Capstone Holding Corp. (OTCQB:CAPS) ("the Company") Effective December 28, 2023, the Company accepted the resignations of Frederic R. Feldman, PhD, and Elwood D. Howse, Jr. from its board of directors. The Company thanks Mssrs. Feldman and Howse fo...
ALSIP, IL / ACCESSWIRE / November 21, 2023 / Capstone Holding Corp. (OTCQB:CAPS) ("the Company") Effective November 16, 2023, the Company reached agreement to revise its accounting treatment for Capstone Beta, LLC's note investment in Diamond Products Holdings, LLC ("DPH") based on the follow...
ALSIP, IL / ACCESSWIRE / August 28, 2023 / Capstone Holding Corp. (OTCQB:CAPS) ("the Company") Effective August 25, 2023, Omar Rabbani resigned in good standing as Chief Financial Officer of the Company. Edward Schultz, formerly Director of Financial Reporting at the Company, has been elected ...
ALSIP, IL / ACCESSWIRE / June 21, 2022 / Capstone Holding Corp. (OTCQB:CAPS) ("the Company") EXERCISE OF SECURED DEBT AND INTEREST CONVERSION OPTION; ISSUANCE OF 78,333 SHARES OF THE COMPANY'S COMMON STOCK On June 15, 2022, BP Peptides, LLC ("Brookstone") exercised its right to conve...
ALSIP, IL / ACCESSWIRE / February 25, 2022 / Capstone Therapeutics Corp. (OTCQB:CAPS) ("the Company") , The Company is please to announce a name change effective on this date to Capstone Holding Corp. Michael Toporek, Chairman and CEO states "The Company has exited the pharmaceutical d...
ALSIP, IL / ACCESSWIRE / December 2, 2021 / Capstone Therapeutics Corp. (OTCQB:CAPS) ("the Company"): The Annual Meeting of Stockholders of Capstone Therapeutics Corp., a Delaware corporation, was held on Wednesday, December 1, 2021 at 11:00 p.m. (local time) at the offices of the Company,...
Capstone Subsidiary Issues Debt to Acquire Equity Interest in Operating Company ALSIP, IL / ACCESSWIRE / April 6, 2021 / On March 31, 2021, the Company, through its relationship with Brookstone Partners (New York), executed definitive documents and acquired a minority interest in a cons...
ALSIP, IL / ACCESSWIRE / December 28, 2020 / Capstone Therapeutics (OTCQB:CAPS) ("the Company"): EXERCISE OF SECURED DEBT AND INTEREST CONVERSION OPTION; ISSUANCE OF 24,900 SHARES OF THE COMPANY'S COMMON STOCK On December 21, 2020, BP Peptides, LLC ("Brookstone") exercised its right to c...
TEMPE, Ariz., March 27, 2020 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB: CAPS) (“the Company”) RECAPITALIZATION OF AND MERGER WITH TOTALSTONE LLC In March 2020, the Company entered into an agreement, which will be effective April 1, 2020, to obtain an interest i...
News, Short Squeeze, Breakout and More Instantly...
Capstone Therapeutics Crp Company Name:
CAPS Stock Symbol:
OTCMKTS Market:
ALSIP, IL / ACCESSWIRE / December 29, 2023 / Capstone Holding Corp. (OTCQB:CAPS) ("the Company") Effective December 28, 2023, the Company accepted the resignations of Frederic R. Feldman, PhD, and Elwood D. Howse, Jr. from its board of directors. The Company thanks Mssrs. Feldman and Howse fo...
ALSIP, IL / ACCESSWIRE / November 21, 2023 / Capstone Holding Corp. (OTCQB:CAPS) ("the Company") Effective November 16, 2023, the Company reached agreement to revise its accounting treatment for Capstone Beta, LLC's note investment in Diamond Products Holdings, LLC ("DPH") based on the follow...
ALSIP, IL / ACCESSWIRE / August 28, 2023 / Capstone Holding Corp. (OTCQB:CAPS) ("the Company") Effective August 25, 2023, Omar Rabbani resigned in good standing as Chief Financial Officer of the Company. Edward Schultz, formerly Director of Financial Reporting at the Company, has been elected ...